Clinical trials
Mobility Limitation trials in Canada with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2013 | 3 |
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Recruiting | 6 |
| Unknown status | 4 |
| Enrolling by invitation | 3 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of British Columbia | 10 |
| McMaster University | 4 |
| University of Toronto | 3 |
| Simon Fraser University | 2 |
| Adria Quigley | 1 |
| Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal | 1 |
| Julie Richardson | 1 |
| McGill University | 1 |
| Regional Geriatric Program of Toronto | 1 |
| Sylvie Nadeau | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mobility Limitation | 33 |
| Multiple Sclerosis | 3 |
| Pain | 3 |
| Brain Injuries | 2 |
| Osteoarthritis | 2 |
| Spinal Cord Injuries | 2 |
| Stroke | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Cerebral Palsy | 1 |
| Cognitive Dysfunction | 1 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.